0001104659-23-073212.txt : 20230621 0001104659-23-073212.hdr.sgml : 20230621 20230621092839 ACCESSION NUMBER: 0001104659-23-073212 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230609 FILED AS OF DATE: 20230621 DATE AS OF CHANGE: 20230621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sabba Stephen L CENTRAL INDEX KEY: 0001442372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 231027964 MAIL ADDRESS: STREET 1: DORSET MANAGEMENT CORP STREET 2: 485 UNDERHILL BLVD SUITE 205 CITY: SYOSSET STATE: NY ZIP: 11791 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 tm2319289-1_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-06-09 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001442372 Sabba Stephen L DORSET MANAGEMENT CORP 485 UNDERHILL BLVD SUITE 205 SYOSSET NY 11791 1 0 0 0 0 Common Stock 2023-06-09 4 A 0 1142 0.00 A 26926 D Non-Qualified Stock Option (right to buy) 73.76 2023-06-09 4 A 0 5461 0 D 2033-06-09 Common Stock 5461 5461 D These securities, as represented in Column 5, include a grant of 1,142 restricted share units approved by the Board of Directors of the Company at the 2023 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date. These securities, as represented in Column 5, were acquired by a grant of 5,461 shares approved by the Board of Directors of the Company at the 2023 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time. The delay in filing was due to inadvertent oversight and this filing is being made at the earliest upon awareness of same. By: /s/ Stephen L. Sabba 2023-06-21